MedTrace Logo

Observational Study to Assess Adherence Oral Anticancer Therapies

NCT03195972 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-11-05

No results posted yet for this study

Summary

Oral anticancer treatments are increasingly numerous. They represent an additional alternative in the therapeutic arsenal of the clinician, and appear to satisfy patients who prefer this route of administration over intravenous treatment. The objective of oral therapies is twofold: to remove the constraints and risks associated with infusions and to allow the patient to follow his treatment at home.

However, they have significant adverse effects that may affect patients, who are sometimes at a disadvantage compared to how they are treated, and potentially lead to non-compliance with the consequences.

This study will identify the factors associated with non-adherence and determine the impact of this non-adherence in terms of treatment efficacy and tolerance.

The aim of this routine care study is to evaluate the adherence to oral anticancer therapies during 3 months.

Conditions

  • Adherence, Patient

Interventions

OTHER

Drug diary filling

patient will fill every day a drug diary

Sponsors & Collaborators

  • Centre Georges Francois Leclerc

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-23
Primary Completion
2016-12-23
Completion
2018-09-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03195972 on ClinicalTrials.gov